Corning Inc led the Series B financing, which NinePoint said would be used to improve patient care by developing medical devices to enable high resolution in-vivo imaging.
NinePoint president and CEO Charles Carignan said, “The NvisionVLE Imaging System is an exciting new imaging technology that is enabling physicians to visualize esophageal abnormalities at and below the mucosal surface, helping inform clinical decision-making.
“With new hospitals adopting the technology every month, and with the support of our investors and strategic guidance of our board, we can continue to expand our sales force to facilitate the adoption of NvisionVLE at more centers.
“Hospitals from New England, to Florida, to California are already offering this advanced imaging technology. We will continue to build out our operational capacity to meet the increasing demand for our products, while also working on new features and product offerings for the future.”
Copyright © 2014 AltAssets